Ultragenyx Pharmaceutical
RARE
#5450
Rank
S$1.95 B
Marketcap
S$19.83
Share price
1.24%
Change (1 day)
-50.54%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: S$1.95 Billion

As of October 2026 Ultragenyx Pharmaceutical has a market cap of S$1.95 Billion. This makes Ultragenyx Pharmaceutical the world's 5450th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.95 B-53.84%
2025S$4.23 B-22.29%
2024S$5.45 B5.09%
2023S$5.18 B19.1%
2022S$4.35 B-43.81%
2021S$7.74 B-36.04%
2020S$12.11 B263.79%
2019S$3.33 B10.24%
2018S$3.02 B14.35%
2017S$2.64 B-36.46%
2016S$4.15 B-32.61%
2015S$6.16 B233.22%
2014S$1.85 B

End of Day market cap according to different sources

On Oct 8th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

S$1.93 Billion
by Nasdaq info icon info icon
S$1.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
S$0.95 B-51.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.04 B-46.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.82 B 198.13%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.58 B 595.01%๐Ÿ‡บ๐Ÿ‡ธ USA